ASX Mkt. Sensitive<p>Lumos Diagnostics ( <a href="https://mastodon-grafa.social/tags/LDX" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>LDX</span></a> ) has released " Lumos Secures Key US Reimbursement Milestones for FebriDx " on Thu 17 Apr at 10:17 AEST <a href="https://mastodon-grafa.social/tags/UnitedStates" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>UnitedStates</span></a> <a href="https://mastodon-grafa.social/tags/Australia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Australia</span></a> <a href="https://mastodon-grafa.social/tags/media" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>media</span></a> <a href="https://mastodon-grafa.social/tags/Strategy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Strategy</span></a> <a href="https://mastodon-grafa.social/tags/live" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>live</span></a> <br><a href="https://grafa.com/asset/lumos-diagnostics-holdings-ltd-8091-ldx.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=ldx.asx" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grafa.com/asset/lumos-diagnost</span><span class="invisible">ics-holdings-ltd-8091-ldx.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=ldx.asx</span></a></p>